Biaryl Compounds Useful as Agonists of the Gpr38 Receptor
AssigneeGlaxo Group Limited
InventorsGregor James MacDonald, Darren Jason Mitchell, Mervyn Thompson, Susan Marie Westaway
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel biaryl derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.
Claims14
A compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof,
- wherein
- A is selected from a 5 or 6 membered heteroaryl ring and an N-linked 5 or 6 membered heterocyclic ring;
- which ring is optionally substituted with 1, 2 or 3 groups independently selected from halogen, C(1-4) alkyl and C(1-4) alkoxy;
- R1 and R2 are independently selected from H or C(1-4) alkyl;
- Y is selected from NH, O and CH2;
- R3 is selected from optionally substituted phenyl and optionally substituted 5 or 6 membered heteroaryl;
- and when R3 is substituted, it may have 1, 2 or 3 substituents, each independently selected from halogen, C(1-4)alkyl, C(1-4)alkoxy, C(3-7)cycloalkyl, hydroxy, trifluoromethoxy, trifluoromethyl, nitro, cyano, phenyl, NH2, NHR4, NR4R5, NHCOR4, NHSO2R4, C(O)CF3, C(O)C(1-4)alkyl, C(O)C(3-7)cycloalkyl, C(O)OC(1-4)alkyl, C(O)OC(3-7)cycloalkyl, OC(O)C(1-4)alkyl, OC(O)C(3-7)cycloalkyl, CONH2, CONHR4, CONR4R5, SOR5, SO2R5, OSO2R5, OSO2CF3, SO2NH2, SO2NHR4 and SO2NR4R5;
- where R4 and R5 may be the same or different and are independently selected from C(1-4) alkyl, phenyl optionally substituted with halogen, and 5 or 6 membered heteroaryl optionally substituted with halogen.
9-12. (canceled)
A method of treatment of a condition or disorder in a mammal which can be mediated via the GPR38 receptor, which comprises administering to the sufferer a therapeutically safe and effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.